Study: Daniel 2013, Journal of Drugs in Dermatology

Shave frequency and regimen variation effects on the management of pseudofolliculitis barbae

Citation

Daniel A, Gustafson CJ, Zupkosky PJ, Candido A et al (2013). Journal of Drugs in Dermatology. PubMed id 23652888.

Open on PubMed

Cards that cite this study (1)

Each card gives its own wording for who was tested, how and what was found.

  • Shaving and razor bumps (pseudofolliculitis barbae) Tier A thin

    A 90 African American men with pseudofolliculitis barbae (PFB) (n=90)

    Randomised to three groups for 12 weeks: shaving 2-3 times a week with standard products, daily with standard products, or daily with advanced products.

    Papule and pustule counts did not differ between groups at 12 weeks, and investigator-graded severity did not differ (P=.43). Ingrown hairs were significantly fewer in the 2-3 times a week group than in either daily group (P=.005 against daily standard, P=.04 against daily advanced). Participants in the daily advanced products group reported more perceived improvement (P=.007) and less itching (P=.002) than the 2-3 times a week group.

    As recorded in this card: Daniel A, Gustafson CJ, Zupkosky PJ, Candido A et al (2013), Journal of Drugs in Dermatology, [primary]

    Note: V2 check against the abstract (efetch, 12 Nov 2026): papule and pustule counts did not differ between groups (P=.32, P=.46); ingrown hairs were fewer in the 2-3 times a week group than in either daily group (P=.005, P=.04); investigator severity did not differ (P=.43). The daily "advanced products" group reported better perceived response (P=.007) and itching (P=.002) than the 2-3 times a week group. The abstract names no product or razor type, so it cannot support single-blade or razor-guard advice. Funding not stated.

This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.